MILLWOOD HOSPITAL
1. Target Overview & Investment Thesis
MILLWOOD HOSPITAL is a 134-bed suburban community hospital in TARRANT, TX with $28.7M in net patient revenue and a 16.5% operating margin. The hospital serves a payer mix of 7.7% Medicare, 0.3% Medicaid, and 92.0% commercial.
Thesis: Turnaround. Our ML models identify $2.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 16.5% to 23.8% (+736bps).
| Net Revenue HCRIS | $28.7M |
| Current EBITDA COMPUTED | $4.7M |
| Operating Margin COMPUTED | 16.5% |
| Occupancy HCRIS | 73.3% |
| Revenue / Bed COMPUTED | $214K |
| Net-to-Gross HCRIS | 33.1% |
| Distress Probability ML | 42.9% |
2. Market Context & Competitive Position
TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 16.5% places it above the state median. Among 172 size-comparable peers (67-268 beds), the median margin is 2.3%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (67-268), prioritizing same-state peers. 172 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| MILLWOOD HOSPITAL (Target) | TX | 134 | $28.7M | 16.5% |
| DELL CHILDRENS MEDICAL CENTER | TX | 262 | $901.9M | 25.5% |
| DRISCOLL CHILDRENS HOSPITAL | TX | 215 | $694.3M | 29.4% |
| ROUND ROCK HOSPITAL | TX | 165 | $681.4M | 8.7% |
| HILLCREST BAPTIST MEDICAL CENT | TX | 236 | $464.8M | -6.7% |
| THE HEART HOSPITAL BAYLOR PLAN | TX | 109 | $464.6M | 25.7% |
| METHODIST RICHARDSON MEDICAL C | TX | 247 | $449.2M | 14.6% |
| DELL SETON MEDICAL CENTER AT T | TX | 225 | $438.6M | -4.2% |
| WOMANS HOSPITAL OF TEXAS | TX | 252 | $435.4M | 67.9% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.1M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $603K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $574K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $568K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $349K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $18K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $4.7M |
| + RCM Uplift | +$2.1M |
| Pro Forma EBITDA | $6.8M |
| Current Margin | 16.5% |
| Pro Forma Margin | 23.8% |
| WC Released (1x) | $1.1M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $7.3M | $52.3M | 7.19x | 48.4% |
| Base (11x exit) | 10.0x | 11.0x | $7.3M | $59.9M | 8.24x | 52.5% |
| Bull Case | 9.0x | 11.0x | $6.5M | $69.2M | 10.58x | 60.3% |
| Bull (12x exit) | 9.0x | 12.0x | $6.5M | $77.4M | 11.84x | 63.9% |
| Bear Case | 11.0x | 10.0x | $8.0M | $39.3M | 4.92x | 37.5% |
| Bear (11x exit) | 11.0x | 11.0x | $8.0M | $45.9M | 5.74x | 41.8% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 172 hospitals with 67-268 beds
- Same-state prioritization (n=173)
- Comp margins: P25=-9.6% / P50=2.3% / P75=12.9%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.